Edition:
United Kingdom

Reckitt Benckiser Group PLC (RB.L)

RB.L on London Stock Exchange

6,413.00GBp
24 May 2019
Change (% chg)

-3.00 (-0.05%)
Prev Close
6,416.00
Open
6,429.00
Day's High
6,448.00
Day's Low
6,382.00
Volume
826,161
Avg. Vol
1,469,744
52-wk High
7,174.00
52-wk Low
5,559.00

Select another date:

Thu, May 9 2019

Photo

Reckitt chairman aims for swift decision on CEO succession

LONDON Reckitt Benckiser is working to resolve both its search for a new chief executive and its position relating to U.S. charges of wrongdoing at a former business, its chairman told investors at its annual general meeting on Thursday.

Reckitt chairman aims for swift decision on CEO succession

LONDON Reckitt Benckiser is working to resolve both its search for a new chief executive and its position relating to U.S. charges of wrongdoing at a former business, its chairman told investors at its annual general meeting on Thursday.

Reckitt chairman aims for swift decision on CEO succession

LONDON, May 9 Reckitt Benckiser is working to resolve both its search for a new chief executive and its position relating to U.S. charges of wrongdoing at a former business, its chairman told investors at its annual general meeting on Thursday.

Reckitt Benckiser first-quarter sales fall short, sees better second half

LONDON Reckitt Benckiser Group reported lower-than-expected first-quarter sales, due to weakness in its health business, but stood by its full-year forecast, relying on an improvement as the year goes on.

UPDATE 2-Reckitt Benckiser Q1 sales fall short, sees better second half

* Shares slip 1.9 percent (Adds details, analyst comment, share move; changes headline)

Reckitt Benckiser Q1 sales miss estimates

LONDON, May 2 Reckitt Benckiser Group reported lower-than-expected first-quarter sales on Thursday, citing a slow start to the year in its health business.

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

(This April 10 story refiles to fix scrambled syntax in paragraph five)

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

(This April 10 story refiles to fix scrambled syntax in fifth paragraph.)

REFILE-UPDATE 6-Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

* Indivior charged in the United States with conspiracy, fraud

Reckitt plays down Indivior risk to infant formula business

LONDON Reckitt Benckiser Group on Wednesday sought to play down any potential impact to its infant formula business from U.S. litigation against Indivior, which it used to own, saying the risk was theoretical and unlikely.

Select another date: